Policy Hurdles in the Fight against Aging

How the FDA characterizes aging plays a large role in how the agency looks at drugs to mitigate or reserve the aging process. Economist Arthur Diamond comments.


Hosted on Acast. See acast.com/privacy for more information.

More from Cato Daily Podcast

  1. 09:26Reputation, Dynamism, and Strangers with CandyApr 25, 2024
  2. 17:41Congressional Fans of Warrantless Surveillance on Americans Win Another RoundApr 24, 2024
  3. 16:45North Carolina Made Big Promises to VinFast and Locals Are Paying the PriceApr 23, 2024
  4. 12:27Wielding Federal Power with Accountability to CongressApr 22, 2024
  5. 12:23Housing Wealth and Generational WealthApr 19, 2024
  6. 13:10Reduce Deficits Now to Avoid Fiscal CrisisApr 18, 2024
  7. 14:13Tariffs Are Taxes, but Who Pays the Tax?Apr 17, 2024
  8. 11:41Bitcoin Mining and the Price of EnergyApr 16, 2024
  9. 06:48Income Taxes Are Scheduled to Go Up in 2026Apr 15, 2024
  10. 10:53What Has the US Promised to Taiwan?Apr 13, 2024